Blue Water Biotech Inc reports results for the quarter ended in June - Earnings Summary

Onconetix

21/10/2023 01:04

* Blue Water Biotech Inc  BWV.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 15 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Blue Water Biotech Inc's reported EPS for the quarter was
a loss
of 43 cents​.
    * The mean earnings estimate of analysts had fallen by
about 25%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Blue Water Biotech Inc shares had fallen by 18.8% this
quarter and lost 62.3% so far this year.
    * The company reported a quarterly loss of $6.87 million.
    * Wall Street's median 12-month price target for Blue Water
Biotech Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 21 at 12:04 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.15          -0.21          Missed
 Mar. 31 2023      -0.21          -0.18          Beat
 Dec. 31 2022      -0.26          -0.20          Beat